论文部分内容阅读
我们用大剂量阿糖胞苷（HD-Ara-C）对完全缓解（CR）后的成人急性髓细胞白血病（AML）住院患者进行早期巩固强化治疗，经1至5年随访观察，发现对延长患者生存期取得较好效果。现报道如下。对象与方法14例AML患者，均经化疗达CR，男性8例，女性6例，就诊时年龄28～48岁，中位年?
We used high-dose cytarabine (HD-Ara-C) for the early consolidation intensive treatment of acutely acute myeloid leukemia (AML) hospitalized patients after complete remission (CR), and after 1 to 5 years of follow-up observation, we found that The patient’s survival period achieved better results. The report is as follows. Subjects and Methods Fourteen patients with AML were treated with chemotherapy, CR, 8 males and 6 females. The age ranged from 28 to 48 years at the time of treatment.